Evotec Forecast, price target & analysts
Evotec Target price 2025 - Analyst rating & recommendation
Evotec Classifications & Recommendation:
Evotec Price Target
| Target Price | €9.89 |
| Price | €5.39 |
| Potential |
83.56%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Evotec 2026 .
The average Evotec target price is €9.89.
This is
83.56%
register free of charge
€12.60
133.77%
register free of charge
€6.06
12.43%
register free of charge
|
|
| A rating was issued by 13 analysts: 9 Analysts recommend Evotec to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Evotec stock has an average upside potential 2026 of
83.56%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 796.97 | 786.16 |
| 1.99% | 1.36% | |
| EBITDA Margin | 2.85% | 4.51% |
| 55.91% | 58.34% | |
| Net Margin | -24.60% | -9.52% |
| 129.12% | 61.31% |
10 Analysts have issued a sales forecast Evotec 2025 . The average Evotec sales estimate is
This results in the following potential growth metrics:
9 Evotec Analysts have issued a net profit forecast 2025. The average Evotec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | -1.11 | -0.42 |
| 136.17% | 62.16% | |
| P/E | negative | |
| EV/Sales | 1.52 |
9 Analysts have issued a Evotec forecast for earnings per share. The average Evotec EPS is
This results in the following potential growth metrics and future valuations:
Current Evotec Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| EQUI.TS |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| EQUI.TS |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Aug 13 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Aug 13 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
